Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,788.71 +11.93 0.43%
FTSE 100 6,710.40 +13.61 0.20%
DAX 8,387.19 +35.21 0.42%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,645.60 -24.12 -0.11%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Idera Pharmaceuticals Inc

+ Add to Watchlist

IDRA:US

0.6950 USD 0.0050 0.72%

As of 20:10:00 ET on 05/23/2013.

Company Profile for Idera Pharmaceuticals Inc (IDRA)

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Contact Information

Idera Pharmaceuticals Inc

167 Sidney Street
Cambridge, MA 02139
United States
Phone: 1-617-679-5500
Fax: 1-617-679-5592

Key Executives for Idera Pharmaceuticals Inc (IDRA)

Sudhir AgrawalChairman/President/CEOLouis J Arcudi IIISenior VP/CFO/Treasurer/Secy
Robert D ArbeitVP:Clinical DevelopmentTimothy M SullivanVP:Dev Programs & Alliance

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil